This document discusses scale-up considerations for tablet production from laboratory to pilot to large scale. Key aspects include:
1) Ensuring raw materials are approved and equipment is qualified during scale-up. Process parameters like mixing times and drying temperatures must be validated.
2) Analytical methods need to be transferred to quality assurance to ensure product stability and uniformity during larger scale production.
3) Granulation, blending, drying, milling, lubrication, compression, and coating equipment may differ between small and large scale, requiring validation of new equipment and processes. Processors can perform multiple steps continuously.
Improved and Novel Excipients – Need, sources of new excipients-co-processing and particle engineering, benefits of co-processed excipients, characterization, examples, regulatory aspects
SOLID DISPERSION
Definition: The technology is the science of dispersing one or more active ingredients in an inert matrix in the solid stage.
Need of solid dispersion:
Increases Oral bioavailability of a drug
Increased dissolution rate.
Enhanced release of drugs from ointment.
Improved the solubility & stability.
The concept of solid dispersion was originally proposed by Sekiguchi & obi.
Increasing the dissolution, absorption & therapeutic efficacy of drugs in dosage forms.
Increasing solubility in water.
Improving the oral absorption and bioavailability of BCS Class II drugs.
Evaluation methods for drug excipients and container interactionSagar Savale
Excipients are one of the three components that in combination produce the medicine that the patient will take.
In therapeutic terms, the API is of primary importance because without it there is no treatment and no product.
In term of drug manufacturing all three of them are equally important so we cannot neglect anyone of them.
The interactions between excipients and the other two components (the API and the manufacturing process), and/or between two or more excipients, are fundamental to the transformation of an API into a medicinal product.
Improved and Novel Excipients – Need, sources of new excipients-co-processing and particle engineering, benefits of co-processed excipients, characterization, examples, regulatory aspects
SOLID DISPERSION
Definition: The technology is the science of dispersing one or more active ingredients in an inert matrix in the solid stage.
Need of solid dispersion:
Increases Oral bioavailability of a drug
Increased dissolution rate.
Enhanced release of drugs from ointment.
Improved the solubility & stability.
The concept of solid dispersion was originally proposed by Sekiguchi & obi.
Increasing the dissolution, absorption & therapeutic efficacy of drugs in dosage forms.
Increasing solubility in water.
Improving the oral absorption and bioavailability of BCS Class II drugs.
Evaluation methods for drug excipients and container interactionSagar Savale
Excipients are one of the three components that in combination produce the medicine that the patient will take.
In therapeutic terms, the API is of primary importance because without it there is no treatment and no product.
In term of drug manufacturing all three of them are equally important so we cannot neglect anyone of them.
The interactions between excipients and the other two components (the API and the manufacturing process), and/or between two or more excipients, are fundamental to the transformation of an API into a medicinal product.
It is the topic of Industrial pharmacy 2 from semester 7 of Bachelor of pharmacy.
It involved all information regarding Pharmaceuticals production scale up technique .role of managers, Engineer and scientists are explained properly .
ROLE OF MANAGER
1. Ensure a safe work environment for all pilot plant operations and compliance with all health and safety policies and procedures.
2.Provide technical leadership and operational oversight of Pilot Plant facility.
3.Partner with Process Development to optimize and implement new processes and technology at the pilot scale.
4.Train engineers and associates in the functional tasks necessary to successfully perform their duties.
5.Schedule activities of pilot plant personnel and ensure the tasks are completed in a timely manner.
6.Provide personnel career development, coaching, and feedback including performance management discussions with each direct report.
7.Train and oversee compliance with Quality Assurance policies and procedures that relate to the Pilot Plant.
8.Write and review standard operating procedures, batch records, process deviations reports, CAPAs, and change control requests.
Manage raw material receipt and release system.
9.Manage plant supplies and raw materials inventory.
Role of engineers:
1.Plant engineers oversee the electrical mechanical systems of a manufacturing plant, from installation to troubleshooting.
2. They are called upon to improve the plant's efficiency, upgrade to new technologies, repair equipment, increase production, and reduce manufacturing issues .
3.Try to process on a model of proposed plant before committing large sum of money on a production unit.
4.Examination of the formula to determine its ability to withstand batch scale & process modification.
5.Evaluation & Validation for process and equipment.
6.To identify the critical features of the process.
Guidelines for production & process controls.
7.To provide master manufacturing formula with instructions for manufacturing procedure.
8.To avoid the scale up problems.
Process of solid ,liquid dosage forms and their guidelines followed along with proper equipment study is provided and the major controls to maintain scale up consideration were mentioned.
When looking to agglomerate material fines, both pelletizing and compaction granulation are often explored. This presentation looks at the differences between these two processes, as well as the advantages and disadvantages to each.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
2. Pilot Plant:- It is the part of the
pharmaceutical industry where a lab
scale formula is transformed into a
viable product by development of liable
and practical procedure of manufacture.
Scale-up:- The art for designing of
prototype using the data obtained from
the pilot plant model.
2
6. 6
Reporting Responsibilities
• R & D with separate staff
• Formulator
Personnel Requirements
• Scientists
• Personnel with engineering
background
Raw materials
• Approved and validated
10. 10
• Weight sheet,
Processing
directions, SOP
Manufacturing
Procedures
Preparation
• Physical and
chemical stability of
the products.
Product
stability and
uniformity
• Quality assurance
staff should review
Transfer of
Analytical
Methods to QA
11. GMP CONSIDERATION
Equipment qualification
Process validation
Regularly scheduled preventive
maintenance
Regular process review and
revalidation
Relevant written SOP
Technically qualified personnel
Training of personnel
Well defined technology transfer
system
Validated cleaning procedures
Orderly arrangement of equipment 11
16. Material handling system
In Lab scale
Large Scale depends on
density and static charge
16
Vacuum loading
Scooped, dumped or
poured by hand
Lifting and tilting drums
Vacuum loading systems
Screw feed systems
Metering pumps
17. Dry Blending
Powders to be used for granulation must be well
blended to ensure good drug distribution.
Inadequate blending at this stage could result in
discrete portion of the batch being either high or
low in potency.
Steps should also be taken to ensure that all the
ingredients are free of lumps and agglomerates.
SCALE UP CONSIDERATIONS
17
Time of blending .
Blender loading.
Size of blender.
18. V- cone blender
The equipment used for
blending are:
18
V- cone blender
Double cone
Ribbon blender
Slant cone
blender
Bin blender
Orbiting screw
blenders vertical
and horizontal
high intensity
mixers.
20. Granulation
wet granulation has been carried
out by
Sigma blade mixer,
Planetary mixer.
20
To impart good flow properties,
increase the density of the powders,
change the particle size,
Uniform dispersion of active ingredient.
22. Wet granulation can also be prepared using
tumble blenders equipped with high-speed
chopper blades
More recently, the use of multifunctional
“processors” that are capable of performing all
functions required to prepare a finished
granulation, such as dry blending, wet
granulation, drying, sizing and lubrication in a
continuous process in a single equipment.
22
23. Binders:
23
Make powders more compressible and to
produce tablets that are more resistant to
breakage during handling.
binding agent imparts viscosity to the granulating
solution so that transfer of fluid becomes difficult
This problem can be overcome by adding some or all
binding agents in the dry powder prior to granulation.
24. Some granulation, when prepared in production
sized equipment, take on a dough-like
consistency and may have to be subdivided to a
more granular and porous mass to facilitate
drying.
This can be accomplished by passing the wet
mass through an oscillating type granulator
with a suitably large screen or a hammer mill
with either a suitably large screen or no screen
at all.
24
25. Drying
The most common conventional method of drying a
granulation continues to be the circulating hot air
oven, which is heated by either steam or electricity.
The important factor to consider as part of scale-up
of an oven drying operation are airflow, air
temperature, and the depth of the granulation on the
trays.
If the granulation bed is too deep or too dense, the
drying process will be inefficient, and if soluble
dyes are involved, migration of the dye to the
surface of the granules.
Drying times at specified temperatures and airflow
rates must be established for each product, and for
each particular oven load.
25
26. Fluidized bed dryers
are an attractive
alternative to the
circulating hot air
ovens.
The important factor
considered as part of
scale up fluidized bed
dryer are optimum
loads, rate of air flow,
inlet air temperature
and humidity.
26
27. Milling
Compression factors that may be affected by the
particle size distribution are flowability,
compressibility, uniformity of tablet weight, content
uniformity, tablet hardness, and tablet color
uniformity.
First step in this process is to determine the particle
size distribution of granulation using a series of
“stacked” sieves of decreasing mesh openings.
Particle size reduction of the dried granulation of
production size batches can be carried out by
passing all the material through an oscillating
granulator, a hammer mill, a mechanical sieving
device, or in some cases, a screening device.
27
28. As part of the scale-up of a milling or sieving
operation, the lubricants and glidants, which in the
laboratory are usually added directly to the final
blend, are usually added to the dried granulation
during the sizing operation.
This is done because some of these additives,
especially magnesium stearate, tend to agglomerate
when added in large quantities to the granulation in
a blender.
28
30. Blending
Type of blending equipment often differs from
that using in laboratory.
In any blending operation, both segregation and
mixing occur simultaneously are a function of
particle size, shape, hardness, and density, and
of the dynamics of the mixing action.
Particle abrasion is more likely to occur when
high-shear mixers with spiral screws or blades
are used.
When a low dose active ingredient is to be
blended it may be sandwiched between two
portions of directly compressible excipients to
avoid loss to the surface of the blender.
30
31. Equipments used for mixing
Sigma blade mixer.
Planetary mixer.
Twin shell blender.
High shear mixer
31
32. Slugging (Dry Granulation)
A dry powder blend that cannot be directly compressed
because of poor flow or compression properties.
This is done on a tablet press designed for slugging, which
operates at pressures of about 15 tons, compared with a
normal tablet press, which operates at pressure of 4 tons or
less.
Slugs range in diameter from 1 inch, for the more easily
slugged material, to ¾ inch in diameter for materials that
are more difficult to compress and require more pressure
per unit area to yield satisfactory compacts.
If an excessive amount of fine powder is generated during
the milling operation the material must be screened & fines
recycled through the slugging operation.
32
33. Dry Compaction
Granulation by dry compaction can also be achieved by
passing powders between two rollers that compact the
material at pressure of up to 10 tons per linear inch.
Materials of very low density require roller compaction
to achieve a bulk density sufficient to allow
encapsulation or compression.
One of the best examples of this process is the
densification of aluminum hydroxide.
Pilot plant personnel should determine whether the final
drug blend or the active ingredient could be more
efficiently processed in this manner than by conventional
processing in order to produce a granulation with the
required tabletting or encapsulation properties.
33
35. Compression
The ultimate test of a tablet formulation and granulation
process is whether the granulation can be compressed on
a high-speed tablet press.
During compression, the tablet press performs the
following functions:
Filling of empty die cavity with granulation.
Precompression of granulation (optional).
Compression of granules.
Ejection of the tablet from the die cavity and take-off of
compressed tablet.
35
36. Tablet Coating
Sugar coating is carried out in conventional coating pans,
has undergone many changes because of new
developments in coating technology and changes in
safety and environmental regulations.
The conventional sugar coating pan has given way to
perforated pans or fluidized-bed coating columns.
The development of new polymeric materials has
resulted in a change from aqueous sugar coating and
more recently, to aqueous film coating.
The tablets must be sufficiently hard to withstand the
tumbling to which they are subjected in either the coating
pan or the coating column.
36
37. 37
Some tablet core materials are
naturally hydrophobic, and in
these cases, film coating with an
aqueous system may require
special formulation of the tablet
core and/or the coating solution.
A film coating solution may
have been found to work well
with a particular tablet in small
lab coating pan but may be
totally unacceptable on a
production scale.
This is because of increased
pressure & abrasion to which
tablets are subjected when batch
size is large & different in
temperature and humidity to
which tablets are exposed while
coating and drying process.
38. REFERENCE
Leon Lachman, Herbert A. Lieberman, The
Theory and Practice of Industrial Pharmacy,
Indian edition 2009, CBS Publishers,
Pg no: 681
N.K.Jain, pharmaceutical product development,
Indian edition2006, CBS Publishers, Pg no:681
38